<DOC>
	<DOCNO>NCT00709293</DOCNO>
	<brief_summary>The restoration normal blood flow follow period ischemia may result ischemia / reperfusion injury ( I/RI ) , characterize inflammation oxidative damage tissue . Varying degree I/RI occur upon reperfusion donor heart cold storage . Medications contain antibody immune cell use many year powerful immunosuppressant . These medication , call polyclonal antibody preparation , generally use immediately follow transplantation and/or treat rejection . At institution , one antibody preparation ( Thymoglobulin ) use pediatric heart transplant recipient 3-5 day immediately transplantation . Because standard immunosuppressive medication ( call calcineurin inhibitor ) toxic kidney , use Thymoglobulin allow u delay initiation calcineurin inhibitor kidneys completely recover shock transplant surgery . We hypothesize Thymoglobulin may beneficial reduce damage cause I/RI . Thus , present study seek evaluate effectiveness intra-operative dose Thymoglobulin ( addition standard dose post-operatively ) reduce effect I/RI . The study double-bind placebo-controlled trial involve 20 subject . Biologic marker I/RI assess periodic interval six month post-transplantation . Subjects receive intra-operative dos Thymoglobulin compare control order ass effectiveness intra-operative Thymoglobulin ameliorate effect I/RI .</brief_summary>
	<brief_title>Role Intraoperative Thymoglobulin Decreasing Ischemia-Reperfusion Injury Pediatric Heart Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>Pediatric population ( age 021 year ) Endstage cardiac disease require heart transplantation Approval listing UCLA Heart Transplant Committee Prior document Thymoglobulin allergy/adverse reaction History current diagnosis lymphoma Documented lymphopenia Documented Thrombocytopenia Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Ischemia Reperfusion Injury</keyword>
	<keyword>Pediatric Heart Transplant</keyword>
	<keyword>ATG</keyword>
	<keyword>Induction Therapy</keyword>
</DOC>